US Physical Therapy Reports Q1 Revenue of $198.3 Million, Below IBES Estimate of $201 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Should l Buy USPH?
Source: moomoo
Physical Therapy Revenue: The physical therapy sector reported a revenue of USD 198.3 million in Q1.
Comparison to Estimates: This figure is slightly below the estimated revenue of USD 201 million.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy USPH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on USPH
Wall Street analysts forecast USPH stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 59.000
Low
100.00
Averages
101.50
High
103.00
Current: 59.000
Low
100.00
Averages
101.50
High
103.00
About USPH
U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 780 outpatient physical therapy clinics in 44 states. Its reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. The Physical Therapy Operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. The IIP segment includes onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Physical Therapy Stock Enters Oversold Territory
- Oversold Status Analysis: U.S. Physical Therapy, Inc. (USPH) has an RSI of 20.2, significantly below the oversold threshold of 30, indicating that the recent decline in stock price may be nearing exhaustion, attracting investors looking for buying opportunities.
- Price Volatility Impact: USPH's stock price fell to a low of $58.55 on Thursday, contrasting sharply with its recent price of $73.65, which translates to an annualized dividend yield of 2.50%, suggesting a higher yield potential for dividend investors at current levels.
- Dividend History Consideration: While dividends are not always predictable, investors should examine USPH's dividend history to assess the likelihood of the recent dividend being sustained, providing a basis for future investment decisions.
- Market Sentiment Shift: Given the current oversold condition, investors may reassess USPH's investment value, especially as market sentiment shifts towards bullishness, potentially leading to increased capital inflow into the stock.
See More
US Physical Therapy Reports Q1 Revenue of $198.3 Million, Below IBES Estimate of $201 Million
Physical Therapy Revenue: The physical therapy sector reported a revenue of USD 198.3 million in Q1.
Comparison to Estimates: This figure is slightly below the estimated revenue of USD 201 million.
See More
U.S. Physical Therapy Reports Disappointing Q1 Earnings
- Disappointing Earnings: U.S. Physical Therapy (USPH) reported a Q1 GAAP EPS of -$0.12, missing expectations by $0.61, indicating significant challenges in profitability.
- Lackluster Revenue Growth: The company generated $198.3 million in revenue for Q1, a 7.9% year-over-year increase, yet fell short of expectations by $2.64 million, reflecting unmet market demand.
- Decline in Operating Results: Q1 non-GAAP operating results were $7.0 million, down from $7.3 million in the same period last year, with operating results per share at $0.46, highlighting pressures on cost control and efficiency improvements.
- Slight Increase in Adjusted EBITDA: The adjusted EBITDA for Q1 was $20.2 million, a $0.7 million increase from $19.5 million in Q1 2025, but overall financial performance remains weak, potentially impacting future investor confidence.
See More
PACS Group Appoints New Chief Financial Officer
- Executive Appointment: PACS Group announced the appointment of Carey P. Hendrickson as Chief Financial Officer, effective April 27, 2026, marking a significant milestone in the company's efforts to expand its national footprint and enhance clinical leadership.
- Extensive Experience: Hendrickson brings nearly four decades of financial leadership, having served as CFO at U.S. Physical Therapy, where he managed the financial operations of 779 outpatient clinics, demonstrating his exceptional capabilities in complex healthcare environments.
- Leadership Transition: Hendrickson succeeds PACS co-founder Mark Hancock, who will retire on June 30, 2026, while remaining as Vice Chairman of the Board, ensuring stability during this transition period for the company.
- Strategic Vision: Hendrickson expressed admiration for PACS's commitment to post-acute care and its leadership culture, looking forward to leveraging his extensive industry experience to contribute to the company's mission.
See More
U.S. Physical Therapy to Report Q1 2026 Results
- Earnings Release Schedule: U.S. Physical Therapy will report its Q1 2026 financial results on May 6, 2026, after market close, followed by a conference call on May 7, indicating the company's commitment to transparency and investor communication.
- Conference Call Details: The conference call is scheduled for May 7, 2026, at 10:30 AM Eastern, requiring participants to dial in 15 minutes early and provide the conference ID, ensuring smooth information dissemination.
- Company Background: Founded in 1990, U.S. Physical Therapy owns and manages 783 outpatient clinics across 44 states, highlighting its extensive influence and market share within the industry.
- Comprehensive Service Offerings: The company provides a wide range of services, including preventative and post-operative care, treatment for neurological injuries, and rehabilitation for injured workers, showcasing its expertise and the demand in the physical therapy and industrial injury prevention sectors.
See More
U.S. Physical Therapy Secures $450 Million Credit Facility
- Credit Facility Expansion: U.S. Physical Therapy has successfully closed a $450 million five-year credit facility, which includes a $175 million term loan and a $275 million revolver, indicating strong market confidence in its financial stability.
- Improved Financing Terms: The credit facility was upsized from an initial $400 million, reflecting robust lender support, while extending the maturity of a previous $325 million facility due in June 2027, thereby enhancing the company's liquidity.
- Key Underwriters Involved: The credit facility was arranged by Bank of America Securities as the Joint Lead Arranger and Sole Bookrunner, with participation from other banks like JP Morgan and Citizens Bank, showcasing the trust and support from multiple financial institutions.
- Stock Price Fluctuation: Despite securing new credit support, USPH shares closed down 1.54% at $77.13 on the New York Stock Exchange, reflecting market uncertainty regarding the broader economic environment.
See More
U.S. Physical Therapy Stock Enters Oversold Territory
- Oversold Status Analysis: U.S. Physical Therapy, Inc. (USPH) has an RSI of 20.2, significantly below the oversold threshold of 30, indicating that the recent decline in stock price may be nearing exhaustion, attracting investors looking for buying opportunities.
- Price Volatility Impact: USPH's stock price fell to a low of $58.55 on Thursday, contrasting sharply with its recent price of $73.65, which translates to an annualized dividend yield of 2.50%, suggesting a higher yield potential for dividend investors at current levels.
- Dividend History Consideration: While dividends are not always predictable, investors should examine USPH's dividend history to assess the likelihood of the recent dividend being sustained, providing a basis for future investment decisions.
- Market Sentiment Shift: Given the current oversold condition, investors may reassess USPH's investment value, especially as market sentiment shifts towards bullishness, potentially leading to increased capital inflow into the stock.
See More
US Physical Therapy Reports Q1 Revenue of $198.3 Million, Below IBES Estimate of $201 Million
Physical Therapy Revenue: The physical therapy sector reported a revenue of USD 198.3 million in Q1.
Comparison to Estimates: This figure is slightly below the estimated revenue of USD 201 million.
See More
U.S. Physical Therapy Reports Disappointing Q1 Earnings
- Disappointing Earnings: U.S. Physical Therapy (USPH) reported a Q1 GAAP EPS of -$0.12, missing expectations by $0.61, indicating significant challenges in profitability.
- Lackluster Revenue Growth: The company generated $198.3 million in revenue for Q1, a 7.9% year-over-year increase, yet fell short of expectations by $2.64 million, reflecting unmet market demand.
- Decline in Operating Results: Q1 non-GAAP operating results were $7.0 million, down from $7.3 million in the same period last year, with operating results per share at $0.46, highlighting pressures on cost control and efficiency improvements.
- Slight Increase in Adjusted EBITDA: The adjusted EBITDA for Q1 was $20.2 million, a $0.7 million increase from $19.5 million in Q1 2025, but overall financial performance remains weak, potentially impacting future investor confidence.
See More
PACS Group Appoints New Chief Financial Officer
- Executive Appointment: PACS Group announced the appointment of Carey P. Hendrickson as Chief Financial Officer, effective April 27, 2026, marking a significant milestone in the company's efforts to expand its national footprint and enhance clinical leadership.
- Extensive Experience: Hendrickson brings nearly four decades of financial leadership, having served as CFO at U.S. Physical Therapy, where he managed the financial operations of 779 outpatient clinics, demonstrating his exceptional capabilities in complex healthcare environments.
- Leadership Transition: Hendrickson succeeds PACS co-founder Mark Hancock, who will retire on June 30, 2026, while remaining as Vice Chairman of the Board, ensuring stability during this transition period for the company.
- Strategic Vision: Hendrickson expressed admiration for PACS's commitment to post-acute care and its leadership culture, looking forward to leveraging his extensive industry experience to contribute to the company's mission.
See More
U.S. Physical Therapy to Report Q1 2026 Results
- Earnings Release Schedule: U.S. Physical Therapy will report its Q1 2026 financial results on May 6, 2026, after market close, followed by a conference call on May 7, indicating the company's commitment to transparency and investor communication.
- Conference Call Details: The conference call is scheduled for May 7, 2026, at 10:30 AM Eastern, requiring participants to dial in 15 minutes early and provide the conference ID, ensuring smooth information dissemination.
- Company Background: Founded in 1990, U.S. Physical Therapy owns and manages 783 outpatient clinics across 44 states, highlighting its extensive influence and market share within the industry.
- Comprehensive Service Offerings: The company provides a wide range of services, including preventative and post-operative care, treatment for neurological injuries, and rehabilitation for injured workers, showcasing its expertise and the demand in the physical therapy and industrial injury prevention sectors.
See More
U.S. Physical Therapy Secures $450 Million Credit Facility
- Credit Facility Expansion: U.S. Physical Therapy has successfully closed a $450 million five-year credit facility, which includes a $175 million term loan and a $275 million revolver, indicating strong market confidence in its financial stability.
- Improved Financing Terms: The credit facility was upsized from an initial $400 million, reflecting robust lender support, while extending the maturity of a previous $325 million facility due in June 2027, thereby enhancing the company's liquidity.
- Key Underwriters Involved: The credit facility was arranged by Bank of America Securities as the Joint Lead Arranger and Sole Bookrunner, with participation from other banks like JP Morgan and Citizens Bank, showcasing the trust and support from multiple financial institutions.
- Stock Price Fluctuation: Despite securing new credit support, USPH shares closed down 1.54% at $77.13 on the New York Stock Exchange, reflecting market uncertainty regarding the broader economic environment.
See More
